A hospital biobank of leftover clinical samples to support rapid diagnostic tests for emerging infectious threats.
Official title: Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions for Emerging Infectious Diseases and CBRN Threats - DiagRaMIE Biobanque
Run by Assistance Publique - Hôpitaux de Paris · NCT07411729 · Data updated 2026-11-12
This project will collect leftover samples from hospitalized adults to help test rapid diagnostic tools for emerging infectious diseases and CBRN threats.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 10 sites (Le Kremlin-Bicêtre and 9 other locations) |
| Status | Recruiting |
| Started | June 3, 2024 |
| Main results expected | June 1, 2026 |
| Study ends | June 1, 2026 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT07411729 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) hospitalized at Bicêtre or Paul Brousse with residual clinical samples available, covered by the French social security system, and able to provide written consent (or with a legal representative) are ideal candidates.
✕Probably not a fit
Patients not hospitalized at the participating centers, those without residual samples, individuals under judicial protection or deprived of liberty, or those unable to consent without a translator are unlikely to directly benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The DiagRaMIE Biobank is a multicenter prospective registry that systematically collects leftover clinical specimens (blood, serum, plasma, respiratory samples, urine, cerebrospinal fluid, biopsies) and linked pseudonymized clinical and microbiological data from hospitalized adults at Bicêtre and Paul Brousse over a three-year inclusion period. No extra procedures or visits are required; samples obtained during routine care are stored securely for up to 20 years. The resource is intended to support development and validation of in vitro rapid diagnostic tests for emerging infectious diseases and CBRN threats, including WHO-prioritized pathogens. Data and specimens will be accessible to qualified developers and researchers to accelerate test evaluation and strengthen epidemic preparedness and patient management.
Why it matters
Potential benefit: If successful, the biobank could speed development and validation of rapid tests so infections are identified faster and outbreaks are controlled sooner.
How similar studies have gone: Hospital biobanks and specimen repositories have previously supported rapid development and validation of diagnostic tests (for example during COVID-19), although collections specifically focused on CBRN threats are less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (≥ 18 years old) hospitalized in one of the participating centers at Bicêtre or Paul Brousse hospitals, for whom residual biological samples are available as part of routine care in one or more participating hospital departments. * Covered by, or entitled to, the French social security system (excluding State Medical Aid - AME). * Patient or legal representative/trusted person informed about the registry and having provided written consent to participate. Exclusion Criteria: * Patients under judicial protection (guardianship or curatorship). * Patients deprived of liberty by judicial or administrative decision. * Patients not speaking French and not accompanied by a translator.
Where it's running
-
CHU Bicêtre
Le Kremlin-Bicêtre, France Recruiting -
CHU Bicêtre
Le Kremlin-Bicêtre, France Recruiting -
CHU Bicêtre
Le Kremlin-Bicêtre, France Recruiting -
CHU Bicêtre
Le Kremlin-Bicêtre, France Recruiting -
CHU Bicêtre
Le Kremlin-Bicêtre, France Recruiting -
CHU Bicêtre
Le Kremlin-Bicêtre, France Recruiting
Show 4 more locations
-
CHU Bicêtre
Le Kremlin-Bicêtre, France Recruiting -
CHU Bicêtre
Le Kremlin-Bicêtre, France Recruiting -
CHU Bicêtre
Le Kremlin-Bicêtre, France Recruiting -
CHU Paul Brousse
Villejuif, France Recruiting
Study contacts
- Study coordinator: Thierry NAAS,, PhD
- Email: thierry.naas@aphp.fr
- Phone: 1 45 21 29 86
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Turning anonymous symptom descriptions into structured biological signals with OpenGenome
This project tries to turn adults' anonymous free-text symptom descriptions submitted to OpenGenome into structured, literature-grounded biological signals using PubMed and ClinicalTrials.gov sources and a constrained reasoning model.
-
Longitudinal study of Victorian children and their parents
This study is looking at the health and wellbeing of children born in Victoria and their parents over time to see how different factors affect their physical and mental health.
-
Long-term follow-up of endocrine and metabolic changes after gestational diabetes
This project will follow women who had gestational diabetes and their children to see if pregnancy and early-life measurements predict later chronic diseases.
-
Graphic health warnings plus pharmacist counseling to help people quit smoking
This project will test whether combining graphic health warnings with pharmacist-led counseling helps adult smokers in Bangladesh and Pakistan quit.
-
Using the WARIFA app to promote healthy lifestyles and manage Type 1 Diabetes
This study is testing whether the WARIFA app can help people with Type 1 Diabetes and those with other health conditions live healthier lives by giving them personalized tips.
-
Evaluating a Turkish digital health readiness questionnaire for chronic diseases
This study tests a Turkish survey to see how ready people with chronic diseases are to use digital health tools to manage their conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.